Dr. Mary Weatherington, Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 1401 Steffen Ave, Lincoln Heights, OH 45215 Phone: 513-588-3623 Fax: 513-588-3649 |
News Archive
In a study that demonstrates the promise of cell-based therapies for diseases that have proved intractable to modern medicine, a team of scientists from the University of Wisconsin-Madison has shown it is possible to rescue the dying neurons characteristic of amyotrophic lateral sclerosis (ALS), a fatal neuromuscular disorder also known as Lou Gehrig's disease.
Trials are being organized for a new therapeutic approach to treating cancer, under exclusive license by Viral Genetics, Inc. According to Scott & White Healthcare Senior Vice President for Research Richard E. Beswick, M.D., who is also assistant dean of research at the Texas A&M Health Science Center College of Medicine, the trials will be conducted at the Glenda Tanner Vasicek Cancer Treatment Center, located at Scott & White in Temple, Texas.
The news comes after the state experienced a whooping cough epidemic in 2010 when 9,000 were infected. Most vulnerable to the disease are infants too young to be fully immunized. Ten babies died after exposure from adults or older children. The last year in which no one died was 1991, when the state recorded just 249 cases of pertussis.
It is early 2015 and Lake B2B has good news for Healthcare marketers. A leader in providing data centric solutions, Lake B2B has launched its 2015 version of 360° marketing platform for healthcare marketers. This self-service login enables marketers to search 10 Million Healthcare Database, create email templates on the fly and launch email and nurturing campaigns with a click.
› Verified 7 days ago